Cibus, Inc. income statement
In fiscal 2025, Cibus, Inc. reported revenue of $3.6m, down 14.6% on the year before, operating income of −$97.5m (a -2680.1% margin) and net income of −$127m, or −$2.78 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 0 | 1 | 0 | 7 | 24 | 26 | 0 | 2 | 4 | 4 | 4 |
| Cost of revenue | 1 | 0 | 0 | — | 9 | 35 | 29 | 0 | — | — | — | — |
| Gross profit | 1 | 0 | 1 | 0 | −2 | −11 | −3 | 0 | — | — | — | — |
| Research and development | 3 | 6 | 12 | 10 | 12 | 11 | 11 | 12 | 42 | 50 | 44 | 37 |
| Selling, general and administrative | 4 | 7 | 15 | 19 | — | — | — | 11 | 29 | 31 | 27 | 21 |
| Selling and marketing | — | — | — | — | 24 | 21 | 15 | — | — | — | — | — |
| General and administrative | — | — | — | — | 19 | 16 | — | — | — | — | — | — |
| Operating income | −6 | −12 | −26 | −28 | −40 | −44 | −29 | −22 | −319 | −258 | −98 | −63 |
| Interest expense | — | 0 | 0 | 1 | 1 | 1 | 1 | 0 | — | — | — | — |
| Income before tax | −6 | −12 | −26 | −28 | −40 | −45 | −29 | −17 | −338 | −283 | −132 | −100 |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −0 | 0 | 0 | 0 |
| Net income | −6 | −12 | −26 | −28 | −40 | −45 | −29 | −17 | −268 | −251 | −127 | −98 |
| Diluted EPS | −$7.33 | −$15.50 | −$28.00 | −$22.75 | −$30.25 | −$33.00 | −$19.50 | −$9.18 | −$12.97 | −$5.42 | −$2.78 | −$1.58 |
| Diluted shares (average) | — | — | — | 1m | 1m | 1m | 1m | 2m | 21m | 46m | 46m | 62m |
| EBITDA | −6 | −12 | −25 | −27 | −38 | −42 | −27 | −21 | −314 | −252 | −92 | −59 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 1 |
| Research and development | 13 | 12 | 12 | 12 | 11 | 9 | 9 | 9 |
| Selling, general and administrative | 8 | 7 | 10 | 7 | 5 | 5 | 5 | 5 |
| Operating income | −200 | −18 | −42 | −18 | −15 | −23 | −12 | −13 |
| Income before tax | −201 | −26 | −49 | −27 | −24 | −32 | −21 | −22 |
| Income tax | 0 | 0 | 0 | 0 | −0 | 0 | 0 | 0 |
| Net income | −180 | −23 | −47 | −25 | −24 | −31 | −21 | −22 |
| Diluted EPS | −$7.63 | −$0.50 | −$1.34 | −$0.61 | −$0.44 | −$0.57 | −$0.33 | −$0.29 |
| EBITDA | −199 | −16 | −40 | −17 | −14 | −21 | −11 | −12 |
Compare with peers
- Arcadia Biosciences, Inc. income statement
- Pinnacle Food Group Ltd income statement
- Where Food Comes From, Inc. income statement
- Farmmi, Inc. income statement
- Immucell Corp income statement
Head to head: CBUS vs RKDACBUS vs PFAICBUS vs WFCF
More: Agricultural Products & Services stocks compared, Consumer Staples sector, rankings of US companies